Clinical trial NCT01159652: Hypnotic Medications and Memory: Effect of Drug Exposure During the Night
Official title: Hypnotic Medications and Sleep-dependent Memory Consolidation: the Effect of Variable Drug Exposure During the Night
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Sleep
Memory
Keywords: sleep
memory
hypnotics
zaleplon
zolpidem
Sonata
Ambien
Hypnotics and Sedatives
Polysomnography
Monitoring, sleep
Lead sponsor: St. Luke's Hospital, Chesterfield, Missouri
Sponsor class: OTHER
Collaborators: name: American Academy of Sleep Medicine
First posted: 2010-07-09
Enrollment: 26
Sex: ALL
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: BASIC_SCIENCE

Brief summary: The purpose of this study is to determine the effect of two hypnotic medications, zolpidem extended release and zaleplon, on memory. It is expected that a hypnotic with shorter drug duration will allow greater memory consolidation than a hypnotic with longer drug duration.

Detailed description: A growing body of evidence has demonstrated that sleep promotes memory consolidation in healthy individuals. However, little research has been conducted regarding the effect of hypnotics on sleep-dependent memory. One study found that zopiclone (7.5 mg), but not brotizolam (0.25 mg), impaired sleep-dependent memory consolidation in normal sleepers. Another study reported significant impairment of sleep-dependent memory on a motor task with triazolam (0.375 mg), but not with zolpidem immediate release (10 mg). These studies provide some evidence that sedative-hypnotic drugs may impair sleep-dependent memory consolidation, but further investigation is clearly needed in this area. Because hypnotics are commonly prescribed for insomnia, it is important to determine if there is a significant risk of impairment in sleep-dependent memory consolidation associated with these medications. Further, investigation of alternative doses and drug regimens upon memory consolidation appears warranted.

The purpose of the current study is to determine the effect of two hypnotic medications on sleep-dependent memory consolidation in normal sleepers. Zolpidem extended release, which will be active for most of the sleep period when administered at bedtime, will be compared to zaleplon, which will be active for half of the sleep period when administered in the middle of the night. This comparison allows us to address the question of whether a few hours of drug-free sleep results in better memory consolidation than sleep with drug throughout the night.

Eligibility criteria: Inclusion Criteria:

* 18 to 50 years of age
* no sleep complaints or problems
* good sleep quality per questionnaire
* sufficient time in bed each night

Exclusion Criteria:

* any clinically significant unstable medical condition
* recent psychiatric disorder
* prior diagnosis or symptoms of a sleep disorder
* recent history of substance abuse
* recent use of prescription hypnotic medication or over-the-counter sleep aid
* recent use of psychotropic medication
* history of adverse reaction to benzodiazepines
* body mass index \> 36
* currently pregnant or nursing
* currently working rotating or night shift
* consumption of \> 700 mg per day of xanthine-containing food or beverages
* consumption of \> 14 units of alcohol per week
* smoke \> 1 pack of cigarettes per day, use of chewing tobacco more than 3 times per day, or unable to refrain from smoking or chewing without distress or discomfort while in the sleep laboratory

Primary outcomes:
measure: Memory
timeFrame: 8 timepoints: 4 evenings and 4 mornings
Secondary outcomes:
Other outcomes:
Locations:
city: Chesterfield
country: United States
facility: St. Luke's Hospital Sleep Medicine and Research Center
state: Missouri
Study officials:
affiliation: St. Luke's Hospital
name: Janine M Hall-Porter, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Greenblatt DJ, Harmatz JS, von Moltke LL, Ehrenberg BL, Harrel L, Corbett K, Counihan M, Graf JA, Darwish M, Mertzanis P, Martin PT, Cevallos WH, Shader RI. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin Pharmacol Ther. 1998 Nov;64(5):553-61. doi: 10.1016/S0009-9236(98)90139-4.
citation: Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance. Fundam Clin Pharmacol. 2006 Aug;20(4):397-403. doi: 10.1111/j.1472-8206.2006.00415.x.